Vedolizumab in the treatment of chronic, antibiotic‐dependent or refractory pouchitis
Vedolizumab in the treatment of chronic, antibiotic‐dependent or refractory pouchitis is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Vedolizumab in the treatment of chronic, antibiotic‐dependent or refractory pouchitis have?
Vedolizumab in the treatment of chronic, antibiotic‐dependent or refractory pouchitis has 83 citations in the OpenAlex counts ScholarIQ stores.
When was Vedolizumab in the treatment of chronic, antibiotic‐dependent or refractory pouchitis published?
Vedolizumab in the treatment of chronic, antibiotic‐dependent or refractory pouchitis has 2017 year in the ScholarIQ index.
What is the open-access status of Vedolizumab in the treatment of chronic, antibiotic‐dependent or refractory pouchitis?
Vedolizumab in the treatment of chronic, antibiotic‐dependent or refractory pouchitis has bronze oa status in the ScholarIQ index.
What is the DOI of Vedolizumab in the treatment of chronic, antibiotic‐dependent or refractory pouchitis?
The DOI for Vedolizumab in the treatment of chronic, antibiotic‐dependent or refractory pouchitis is on the source record.
What is the PMID of Vedolizumab in the treatment of chronic, antibiotic‐dependent or refractory pouchitis?
The PMID for Vedolizumab in the treatment of chronic, antibiotic‐dependent or refractory pouchitis is on the source record.
What is the OpenAlex record for Vedolizumab in the treatment of chronic, antibiotic‐dependent or refractory pouchitis?
The OpenAlex for Vedolizumab in the treatment of chronic, antibiotic‐dependent or refractory pouchitis is on the source record.